Suppr超能文献

噬菌体 vB_EfaS-271 对. 的潜在应用中噬菌体-细菌相互作用

Phage-Bacteria Interactions in Potential Applications of Bacteriophage vB_EfaS-271 against .

机构信息

Department of Molecular Biology, University of Gdansk, Wita Stwosza 59, 80-308 Gdansk, Poland.

Laboratory of Phage Therapy, Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Kładki 24, 80-822 Gdansk, Poland.

出版信息

Viruses. 2021 Feb 19;13(2):318. doi: 10.3390/v13020318.

Abstract

Phage therapy is one of main alternative option for antibiotic treatment of bacterial infections, particularly in the era of appearance of pathogenic strains revealing resistance to most or even all known antibiotics. is one of such pathogens causing serious human infections. In the light of high level of biodiversity of bacteriophages and specificity of phages to bacterial species or even strains, development of effective phage therapy depend, between others, on identification and characterization of a large collection of these viruses, including understanding of their interactions with host bacterial cells. Recently, isolation of molecular characterization of bacteriophage vB_EfaS-271, infecting strains have been reported. In this report, phage-host interactions are reported, including ability of vB_EfaS-271 to infect bacteria forming biofilms, efficiency of eliminating bacterial cells from cultures depending on multiplicity of infection (m.o.i.), toxicity of purified phage particles to mammalian cells, and efficiency of appearance of phage-resistant bacteria. The presented results indicate that vB_EfaS-271 can significantly decrease number of viable cells in biofilms and in liquid cultures and reveals no considerable toxicity to mammalian cells. Efficiency of formation of phage-resistant bacteria was dependent on m.o.i. and was higher when the virion-cell ratio was as high as 10 than at low (between 0.01 and 0.0001) m.o.i. values. We conclude that vB_EfaS-271 may be considered as a candidate for its further use in phage therapy.

摘要

噬菌体疗法是治疗细菌感染的一种主要替代抗生素的方法,尤其是在出现对大多数甚至所有已知抗生素都具有耐药性的致病菌株的时代。是导致严重人类感染的病原体之一。鉴于噬菌体的高度生物多样性和噬菌体对细菌物种甚至菌株的特异性,有效的噬菌体疗法的发展取决于对这些病毒的大量收集进行鉴定和表征,包括了解它们与宿主细菌细胞的相互作用。最近,已经报道了感染 菌株的噬菌体 vB_EfaS-271 的分离和分子特征。在本报告中,报告了噬菌体-宿主相互作用,包括 vB_EfaS-271 感染形成生物膜的细菌的能力、根据感染复数(m.o.i.)从培养物中消除细菌细胞的效率、纯化噬菌体颗粒对哺乳动物细胞的毒性以及噬菌体抗性细菌出现的效率。所呈现的结果表明,vB_EfaS-271 可以显著减少生物膜和液体培养物中存活的 细胞数量,并且对哺乳动物细胞没有明显的毒性。噬菌体抗性细菌形成的效率取决于 m.o.i.,当病毒体-细胞比高达 10 时比低(在 0.01 到 0.0001 之间)m.o.i.值时更高。我们得出结论,vB_EfaS-271 可以被认为是进一步用于噬菌体治疗的候选物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/562f/7922982/53dfd73b4688/viruses-13-00318-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验